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Abstract
Lifestyle modifications, including physical exercise (PhyEx), are well-known treatments 
for metabolic syndrome (MetS), a cluster of metabolic and cardiovascular risk factors 
often associated to hypogonadism. Given the trophic role of testosterone on skeletal 
muscle (SkM), this study was aimed at evaluating the effects of testosterone treatment 
on SkM metabolism and exercise performance in male rabbits with high-fat diet (HFD)-
induced MetS. HFD rabbits, treated or not with testosterone (30 mg/kg/week) for 
12 weeks, were compared to regular diet animals (RD). A subset of each group was 
exercise-trained for 12 weeks. HFD increased type-II (fast, glycolytic) and decreased 
type-I (slow, oxidative) muscle fibers compared to RD as evaluated by RT-PCR and 
histochemistry. Testosterone reverted these effects, also inducing the expression of 
mitochondrial respiration enzymes and normalizing HFD-induced mitochondrial cristae 
reduction. Moreover, testosterone significantly increased the expression of myogenic/
differentiation markers and genes related to glucidic/lipid metabolism. At the end of 
the PhyEx protocol, when compared to RD, HFD rabbits showed a significant reduction 
of running distance and running time, while testosterone counteracted this effect, 
also decreasing lactate production. In the trained groups, muscle histology showed 
a significant reduction of oxidative fibers in HFD compared to RD and the positive 
effect of testosterone in maintaining oxidative metabolism, as also demonstrated by 
analyzing mitochondrial ultrastructure, succinate dehydrogenase activity and ATP 
production. Our results indicate that testosterone could be useful to promote oxidative 
muscle metabolism altered by MetS, thus improving exercise performance. Conversely, 
testosterone administration to otherwise eugonadal rabbits (RD) only increased muscle 
fiber diameter but not endurance performance.
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Introduction
Metabolic syndrome (MetS) is a clustering of different 
metabolic alterations and cardiovascular risk factors, 
with insulin resistance being one of the main pathogenic 
factors. In men, MetS is also associated with a sex 
hormone imbalance characterized by low testosterone 
and gonadotropin levels, leading to hypogonadotropic 
hypogonadism (HH). The mechanism(s) underlying this 
association are complex and not fully elucidated. In 
fact, hormonal imbalance (low testosterone, increased 
estrogen/testosterone ratio) may be a consequence of 
metabolic dysregulation, but the converse may also 
apply with MetS being a consequence of testosterone 
deficiency (Morelli et  al. 2016). Hence, the direction of 
this association is still undetermined.
The etiology of MetS is multifactorial and comprises 
both genetic and lifestyle factors (Morelli et  al. 2016, 
Cangiano et al. 2019). The prevalence of MetS is increasing 
in all age/ethnic groups worldwide, primarily due to 
modifiable factors such as increased sedentary screen 
time, physical inactivity and diet (Roberts & Barnard 
2005). Lifestyle modifications, including both dietary 
and physical training interventions, are well-known 
treatments for MetS. Exercise and physical activity are 
recommended for either the primary management of 
MetS individual risk factors (Pedersen & Saltin 2015) or for 
the prevention of MetS itself (Lakka & Laaksonen 2007). 
Moreover, physical activity levels and cardiorespiratory 
fitness display notable inverse relationships with MetS 
prevalence (Church 2011, Ingle et al. 2017). In particular, a 
recent review highlighted that aerobic exercise, conducted 
for a minimum duration of 12 weeks (three times/week), 
is beneficial for individuals with MetS without diabetes, 
with improvements in several cardiovascular risk factors 
(Wewege et al. 2018).
Skeletal muscle is the most abundant tissue in 
humans and represents 40–60% of total body weight in 
normal women and men, with a variety of physiological 
functions. Muscle loss results, therefore, in both physical 
alterations and metabolic derangements (Abrigo et  al. 
2016). Since skeletal muscle accounts for 80% of insulin-
stimulated uptake of glucose, it represents one of the 
principal tissues for evaluating mechanism(s) related to 
insulin resistance (Stuart et al. 2013).
Muscles have a heterogeneous composition with a 
mosaic of different fiber types with peculiar physiological 
contractile properties. Skeletal muscle fibers are primarily 
classified as ‘slow-twitch’ (type I) and ‘fast-twitch’ (type II). 
Moreover, based on differential myosin heavy chain 
(MYH) gene expression, there is a further classification of 
fast-twitch fibers into three major subtypes (types IIA, IIX, 
and IIB). Type I fibers primarily use oxidative metabolism 
and are more resistant to fatigue, while type II fibers 
partially or completely rely upon glycolytic metabolism 
ranging from IIA > IIX > IIB (Schiaffino & Reggiani 2011). 
Muscle is a versatile tissue and is capable of changing 
phenotypic properties in response to hormonal, 
lifestyle and environmental cues. Muscle metabolism 
and performance depend upon muscle plasticity and, 
therefore, upon the relative proportion of the fiber types. 
For example, it was demonstrated that the proportion of 
slow fibers is significantly increased in response to exercise 
training (Pette 2002).
Skeletal muscle mass is mainly regulated by exercise 
training, nutrition and hormonal stimuli that control 
anabolic-catabolic balance, glucose metabolism, muscle 
mass maintenance and reparation after injury. It is 
well known that sex steroids, in particular androgens, 
promote the growth/maintenance of muscle mass and 
strength and exert beneficial effects on metabolism and 
on fiber repair after injury (Carson & Manolagas 2015). 
Thus, physiologic or pathologic changes in the levels of 
circulating sex steroids have important implications for 
muscle health in both genders (Carson & Manolagas 
2015). Healthy hypogonadal men and individuals with 
androgen deficiency (as in androgen deprivation therapy 
for prostate cancer or administration of GnRH agonists) 
have lower muscle size, strength and function, higher fat 
mass and higher incidence of insulin resistance, when 
compared to age-matched eugonadal men (Grinspoon 
et  al. 1996, Bhasin et  al. 2004, Gonzalez et  al. 2016). 
Moreover, some studies demonstrated a correlation 
between the age-associated decline in serum testosterone 
levels and the reduced mass and strength in male lower 
limbs (Morley et  al. 1997, Baumgartner et  al. 1999, Roy 
et al. 2002). On the contrary, a dose-dependent increase 
in fat-free mass, muscle size, muscle protein synthesis 
and maximal voluntary strength was observed both in 
healthy androgen-deficient (Finkelstein et al. 2013) and in 
eugonadal men treated with graded doses of testosterone 
(Bhasin et al. 2004). Accordingly, a recent meta-analysis 
of randomized controlled trials (RCTs) employing 
testosterone treatment (TTh) and reporting data on body 
composition indicates that TTh is able to increase muscle 
mass and, as a consequence, glucose metabolism (Corona 
et  al. 2016). In particular, TTh determines muscle fiber 
hypertrophy (i.e. increase in muscle fiber cross-sectional 
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area), but not hyperplasia, with an increase in satellite cell 
and in myonuclear number (Sinha-Hikim et al. 2002).
In MetS subjects, it has been demonstrated that 
skeletal muscles had a different arrangement of fibers 
respect to healthy subjects, with a significant reduction of 
type I fibers and a resulting muscle composition similar to 
that of patients with type 2 diabetes (Stuart et al. 2013). 
In addition, individuals with higher type I fiber content 
have a reduced risk for developing MetS and diabetes 
(Hernandez et al. 2001).
Animals fed a high-fat diet (HFD) show an impairment 
of muscle function and, specifically, the development of 
the typical features of muscle wasting (such as weakness, 
loss of muscle mass, decreased fiber diameter) and 
atrophy (Bhatt et  al. 2006, Sishi et  al. 2011). In HFD 
male mice, a decline in type I fibers and an increase in 
type I/IIA hybrid fibers were observed, suggesting that 
the type I fibers were transformed primarily into these 
hybrids and are most susceptible to the effects of obesity 
(Denies et al. 2014).
During the last 10 years, we set up a non-
genetic model of MetS by feeding male rabbits with 
a high-fat, cholesterol-rich, diet (HFD). The resulting 
phenotype showed typical features of the human MetS 
(increased visceral obesity, hypertension, dyslipidemia, 
glucose intolerance), including hypogonadotropic 
hypogonadism, with a significant reduction of plasma 
testosterone and gonadotropins (FSH, LH), along with 
a decrease in testis and seminal vesicle weights (Filippi 
et  al. 2009). In this experimental model, sex hormone 
imbalance was related to MetS severity, since testosterone 
decreased and E increased as a function of the number 
of MetS components (Morelli et al. 2016). Interestingly, 
we recently demonstrated that, when HFD rabbits were 
trained with aerobic physical activity on a treadmill, they 
exhibited a reversal of the hypogonadotropic condition, 
including a restoration of the hypothalamic network 
controlling GnRH production. However, these animals 
also showed a deficient muscular response to fatigue, as 
demonstrated by a significant reduction of both running 
distance and running time in comparison to the control 
group fed a regular diet (Morelli et  al. 2019). Hence, 
they are less prone to perform physical exercise. Given 
the well-known trophic role of testosterone on skeletal 
muscle (SkM) mass, in this study, we extended the 
previous findings with the aim of analysing the effects 
of HFD on SkM composition and metabolism, along with 
the possible beneficial role of testosterone in preventing 
these effects and in improving exercise performance in 
the HFD-induced MetS model.
Materials and methods
Animals’ treatment
Adult male New Zealand White rabbits (Charles River), 
weighing about 3 kg (15 weeks old), were individually 
caged under standard conditions in a temperature and 
humidity controlled room on a 12 h light:12 h darkness 
cycle. Water and food were unrestricted throughout the 
study and food intake was daily measured. After 1 week 
of regular diet (Harlan-Global Diet 2030, produced by 
Mucedola s.r.l, Milan, Italy; water 12%, protein 16.5%, 
fiber 15.5%, ash 8.5% and vegetable-derived fat 3.5%, 
total calories 3750 kcal/kg), animals were randomly 
divided into three groups: (1) control rabbits continued 
to receive a regular diet (RD group; n = 25); (2) treatment 
rabbits received a high-fat diet (HFD) enriched by 0.5% 
animal-derived cholesterol and 4% peanut oil, total 
calories 4000 kcal/kg (HFD group; n = 27), (3) HFD 
rabbits supplemented with a pharmacological dose of 
testosterone (30 mg/kg weekly i.m.; HFD + testosterone 
group; n = 25), as previously described (Filippi et al. 2009). 
To evaluate the effect of testosterone in control animals, 
an additional group of RD rabbits was supplemented 
with a pharmacological dose of testosterone (30 mg/kg 
weekly i.m.; RD + testosterone group, n = 8) for 12 weeks. 
A subset of rabbits for each group (RD, n = 10; HFD, n = 12; 
HFD + testosterone, n = 10; RD + testosterone n = 4) was 
trained with a physical exercise (PhyEx) running protocol 
on a treadmill with increasing intensity, duration and 
frequency during the 12 weeks, as previously published 
(Morelli et al. 2019) and described below. The remaining 
animals were left in the cages for the same period. The 
diet and training began at the same time and lasted 
12 weeks. PhyEx rabbits were killed 90 min after the end of 
the exercise. Blood samples for glucose, total cholesterol, 
triglycerides, LH and testosterone measurements were 
collected as previously described (Morelli et  al. 2019). 
In particular, for the PhyEx rabbits, blood samples were 
obtained immediately before (pre-exercise), immediately 
after (end exercise) and 90 min after the end (recovery) 
of the last exercise at week 12 for measuring blood lactate 
concentration, testosterone, LH, glucose and triglycerides. 
Mean arterial blood pressure (MAP) was measured and 
afterward, the rabbits were killed by a lethal dose of 
pentobarbital (Morelli et al. 2019). After killing, the vastus 
medialis muscle was rapidly dissected and appropriately 
stored for the subsequent analyses. To evaluate the 
prevalence of MetS, we previously designed an algorithm 
taking into account the presence, as a dummy variable, 
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of one or more of the following factors: hyperglycemia, 
high triglycerides, high cholesterol, increased blood 
pressure, and visceral fat accumulation. Cutoffs for each 
factor were derived by the mean ± two s.d. of the analyzed 
parameter, as measured in a large database concerning 
RD rabbits (n = 96). Positivity for three or more factors 
identifies MetS (Maneschi et al. 2012). Animal handling 
complied with the Institutional Animal Care and Use 
Committee of the University of Florence, Florence, Italy, 
which approved the study, in accordance with Italian 
Ministerial Law, n. 326/2013-B.
Physical exercise protocol
The physical exercise protocol consisted of a 12-week 
period of running on a treadmill designed to accommodate 
rabbits and produced by AL.TO. (Cavezzo, Modena, Italy). 
During the first 2 weeks, the rabbits ran 2 days/week at a 
treadmill speed of 10 m/min for 3 min with no inclination 
(0%). From the third week of treatment, the running 
speed and period were gradually increased with caution: 
in the third week, the rabbits ran for 5 min at 10 m/min 
continuously (2 days/week) with inclination (20%). 
During subsequent weeks, either the running velocity 
was extended 5 m/min each week until they could run 
at a speed of 20 m/min (from week 6) and the running 
time was extended 5 min each week until they could run 
for 25 min per day or until exhausted, with inclination 
(20%). From week 4, they were trained for 3 days/week for 
a total of 9 weeks. Exhaustion was objectively determined 
when the rabbit refused to run any longer and typically 
lay down and stretched its hindlimbs. During the 
exercise, animals were constantly monitored, and when 
they stopped running, the experiment was immediately 
considered concluded and the animals were moved to 
their cages under standard conditions. No adverse events 
from the exercise were registered.
Plasmatic levels of cholesterol, triglycerides, glucose, 
testosterone, LH, and lactate
Plasma cholesterol, triglycerides and glucose levels were 
measured by using an automated system (ADVIA 2004 
Siemens Chemistry System; Siemens Science Medical 
Solution Diagnostic), as previously described (Filippi et al. 
2009). Plasma testosterone and LH levels were measured 
using a chemiluminescence system (Immunolite 
2000 Siemens, Siemens Healthcare Diagnostics) and 
an ELISA kit (Repropharm Vet, Nouzilly, France), 
respectively, as previously described (Morelli et al. 2019). 
Lactate was measured using an automated system 
according to the manufacturer’s instructions (Lactate 
Scout, EKF Diagnostic-SensLab, Leipzig, Germany).
Oral glucose tolerance test
Oral glucose tolerance test (OGTT) was performed as 
previously published (Filippi et  al. 2009). Briefly, after 
an overnight fasting, a glucose solution (1.5 g/kg) was 
orally administered to the animals and blood samples 
were collected before and 15, 30, and 120 min after 
glucose loading for plasma glucose measurement. The 
incremental area under the curve (iAUC) was calculated 
using GraphPad Prism software, version 5.0 for Windows.
RNA extraction and quantitative RT-PCR analysis
Isolation of total RNA from frozen muscles and RT-PCR 
analysis were performed as previously described (Morelli 
et  al. 2019). Briefly, for isolation a TRIzol reagent (Life 
Technologies) and RNeasy Mini Kit (Qiagen) were utilized. 
cDNA synthesis was carried out using the iScript™ cDNA 
Synthesis Kit (Bio-Rad Laboratories). Quantitative real-
time RT-PCR (qRT-PCR) amplification and detection 
were carried out using SsoAdvanced™ Universal SYBR® 
Supermix and a CFX96 Two-Color Real-Time PCR 
Detection System (Bio-Rad Laboratories). Specific PCR 
primers for rabbit target genes were designed based on 
sequences available at NCBI GenBank (https://www.ncbi.
nlm.nih.gov/genbank/) or Ensemble Genome (http://
www.ensembl.org). The 18S rRNA subunit was used as 
the reference gene for the relative quantification of the 
target genes based on the comparative threshold cycle 
(Ct) 2−ΔΔCt method.
Histomorphometric analysis, fiber typing and  
Oil Red O staining
Some blocks of vastus medialis muscle were embedded 
in paraffin and used for morphometric evaluation and 
periodic acid–Schiff (PAS) staining. In detail, deparaffinized 
and rehydrated 5 μm thick cross-sections were processed 
using standard hematoxylin-eosin staining, and fiber 
diameter was calculated using Image J 1.51f software 
(National Institutes of Health) in ten random images 
from at least three animals for each experimental group. 
Additional sections were stained with PAS (Bio-Optica 
S.p.A., Milan, Italy) according to the manufacturer’s 
instructions. Light, medium and dark PAS stained fibers 
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were counted in ten random images from at least three 
animals for each experimental group.
Immediately after collection, other tissue blocks from 
the muscle belly were affixed to a cork disc with OCT 
support medium (Sakura Fintek Europe, Zoeterwoude, 
Netherlands), then frozen by immersion in isopentane, 
kept at the freezing point in liquid nitrogen, and stored 
at −80°C. Transverse muscle cryostat sections (8-μm 
thick) were stained with a SDH assay or Oil Red O kit, 
following the manufacturer’s instructions (Bio-Optica 
S.p.A.). The number of SDH positive fibers was counted 
in ten random images from at least three animals for each 
experimental group.
Immunohistochemistry
Deparaffinized and rehydrated 5-μm-thick sections 
of vastus medialis muscle were processed using 
immunohistochemical procedures. Briefly, sections were 
incubated overnight at 4°C with mouse monoclonal anti-
PAX-7 primary antibody (1:50 dilution; sc-81975, Santa 
Cruz Biotechnology) or anti-MYH3 primary antibody 
(1:30 dilution; sc-53091, Santa Cruz Biotechnology) and 
subsequently with biotinylated anti-mouse (Thermo 
Scientific) followed by streptavidin-peroxidase complex 
(Thermo Scientific). The reaction product was developed 
with 3′,3′-diaminobenzidine tetrahydrochloride as 
chromogen (Sigma-Aldrich). Negative controls were 
performed avoiding primary antibody. Slides were 
evaluated and photographed using a Nikon Microphot-
FXA microscope. The number of PAX-7 positive cells 
was counted in ten fields from three animals for each 
group and expressed as a percentage of the RD group 
(mean ± s.e.m.).
Electron microscopy
Skeletal muscle specimens were fixed in 4% glutaraldehyde 
in 0.1 M cacodylate buffer, pH 7.4, for 24 h, post-fixed 
in 1% osmium tetroxide in 0.1 M phosphate buffer, pH 
7.4, for 1 h, dehydrated in graded acetone and embedded 
in Epon 812 epoxy resin (Fluka, Buchs, Switzerland). 
Ultrathin sections were stained with uranyl acetate and 
alkaline bismuth sub nitrate and examined under a JEM 
1010 electron microscope (JEOL) at 80 kV. Micrographs 
were taken at ×50,000 final magnification using a 
Mega View III digital camera (SIS-Soft Imaging System, 
Munster, Germany) in at least ten fields for each sample. 
Mitochondrial and internal cristae surface area was 
measured using iTEM image analysis software (SIS-Soft).
Triglycerides content
Triglycerides content from skeletal muscle biopsies 
in six animals from each experimental group was 
evaluated using the Triglyceride Quantification 
Colorimetric/Fluorometric Kit (BioVision), following the 
manufacturer’s instructions. Briefly, 100 mg of frozen 
tissue was mechanically homogenized and resuspended 
in 1 mL solution containing 5% NP-40 in water, heated 
to 80–100°C to solubilize all triglycerides and centrifuged 
at top speed for 2 min. Lipase was subsequently added 
and incubated for 20 min at room temperature to convert 
triglycerides to glycerol and fatty acids. After the addition 
of Triglyceride Reaction Mix, absorbance at 570 nm was 
read with a plate reader (Victor3 1420, Perkin Elmer).
Tissue homogenates and lysates preparation
Homogenates were prepared, and succinate 
dehydrogenase (SDH) activity was measured as previously 
described (see below and Rapizzi et al. 2015). Small frozen 
skeletal muscle sections were first chopped finely, and 
samples were then homogenized in a hand-held plastic 
homogenizer (80 strokes), in a solution containing 
120 mM KCl, 20 mM HEPES, 2 mM MgCl2, 1 mM EGTA 
and 5 mg/mL BSA. Homogenates were centrifuged at 800 g 
for 10 min at 4°C, and the enzymatic assay was performed 
on the supernatant. For lysates, pieces of finely chopped 
skeletal muscle were lysed in buffer containing 50 mM 
Tris–HCl pH = 7.5, 120 mM NaCl, 1 mM EGTA, 6 mM EDTA, 
15 mM Na4P2O7, 20 mM NaF and 1% Triton X-100 
protease inhibitor cocktail. Lysates were clarified by 
centrifugation at 10,000 g for 15 min at 4°C. All passages 
were carried out on ice. All supernatants were quantified 
for protein content (Coomassie Blue reagent was from 
Bio-Rad Laboratories).
Western blot analysis
Lysates (25 μg of protein) were separated by SDS/PAGE 
and transferred onto PVDF (Immobilon, Millipore), 
as previously described (Rapizzi et  al. 2015). Bound 
antibodies were detected using ECL reagents (Immobilon, 
Millipore) and analyzed with a Bio-rad ChemiDoc 
Imaging System for dedicated chemiluminescent image 
acquisition (Quantity-One Imaging and Analysis Software 
by Bio-Rad). Primary antibodies against subunit A of 
SDH (1:5000 dilution; ab14715, Abcam), actin (1:5000 
dilution; sc-1615, Santa Cruz Biotechnology) and TOM20 
(1:5000 dilution; cat. 612278, BD Biosciences) were used. 
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Secondary antibodies were obtained from Santa Cruz 
Biotechnology (anti-mouse sc-2005, anti-goat sc-2020).
SDH activity
Tissue homogenates (50 μg) were incubated in 
a phosphate buffer containing sodium azide, 
2,6-dichlorophenolindophenol (DCPIP), sodium succinate 
and phenazine methosulfate. Complex II specific activity 
was evaluated by photometry, using the Victor3 1420 
Multilabel Counter (Packard Instruments, Perkin-Elmer), 
measuring the decrease in absorbance due to oxidation of 
DCPIP at 600 nm (Rapizzi et al. 2015).
Intracellular ATP
ATP levels were measured using CellTiter-Glo 
luminescent cell viability assay (Promega). Briefly, muscle 
homogenates (25 μg/50 μL) were plated in duplicates in 
a 96-well plate, and an equal volume of CellTiter-Glo 
reagent was added. Suspensions were shaken at 300 rpm 
on an orbital shaker for 5 min and then incubated at 
room temperature for 25 min to stabilize the luminescent 
signal. Luminescence was measured using the Victor3 
1420 Multilabel Counter (Packard Instruments, 
Perkin-Elmer).
Statistical analysis
Statistical analysis was performed with a one-way ANOVA 
test (Kruskal–Wallis) followed by Mann–Whitney post 
hoc analysis or with unpaired two-sided Student’s t-test, 
respectively, for non-normally and normally distributed 
parameters, to evaluate differences between groups. 
Results are expressed as mean ± s.e.m. for normally 
distributed parameters and median with interquartile 
range for parameters with non-normal distributions. 
Correlations were assessed using Spearman’s methods. 
Multilevel mixed-effects linear regressions were used 
for assessing the acute effect of physical exercise over 
the running and the recovery time in the experimental 
groups. The models, nested within the animals, were fitted 
using the treatment group (RD + PhyEx, HFD + PhyEx or 
HFD + testosterone + PhyEx), time of exercise (pre-exercise, 
end exercise and recovery) and their interaction term as 
the independent variables and the serum parameters as 
the dependent variables. A P value <0.05 was considered 
as significant in all the analyses. Statistical analysis was 
performed with Statistical Package for the Social Sciences 
(SPSS v.25.0; SPSS Inc.).
Experimental procedures were carried out using the 
facilities of the Molecular Medicine Facility, Department 
of Biomedical Experimental and Clinical Sciences ‘Mario 
Serio’, University of Florence.
Results
MetS phenotype induced by HFD
HFD rabbits showed a significant increase in all MetS 
components. In fact, as shown in Table 1, they have 
hyperglycemia, glucose intolerance, dyslipidemia, 
hypertension and increase in visceral fat. More than 
three MetS components were present in 72.7% of HFD-
treated rabbits, whereas it was completely absent in RD 
rabbits with or without PhyEx (P < 0.0001). Testosterone 
supplementation to HFD rabbits significantly decreased 
the percentage of rabbits satisfying MetS criteria 
(9.1%, P = 0.002). This percentage was further reduced 
to 0% in HFD rabbits performing PhyEx and treated 
with testosterone (Table 1). PhyEx alone numerically 
reduced the percentage of MetS rabbits (66.7%), but the 
difference was not statistically significant from the HFD 
group (P = 0.79).
The occurrence of a HFD-associated hypogonadotropic 
hypogonadism was demonstrated by the significant 
reduction of both circulating testosterone and LH levels 
(Table 1). Treatment with testosterone (TTh; 30 mg/kg/week 
for 12 weeks) did not affect HFD-induced dyslipidemia, 
while significantly ameliorated MAP, and exerted a 
remarkable positive effect on fasting glucose levels, glucose 
tolerance, and visceral adipose tissue accumulation 
(Table 1). As expected, in testosterone-treated rabbits, 
LH levels remained suppressed (Table 1). Moreover, 
no significant differences were observed concerning 
body weight measurements among the different groups 
(Table 1). Daily food intake in HFD-fed rabbits was not 
statistically different, as compared to RD-fed rabbits 
(127.85 g (108.04–150.48) and 138.7 g (121.7.50–155.61), 
respectively; P = 0.154).
Effects of HFD and TTh on skeletal muscle 
composition
To characterize the fiber type composition of skeletal 
muscle samples from each experimental group, we 
analyzed the mRNA expression of myosin heavy chain 
(MYH) isoforms, responsible for the contractile properties. 
We therefore investigated the four fiber types in 
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mammalian muscle (type I, IIA, IIX, and IIB), according 
to the expression of MYH isoform: MYH4 for IIB (very 
fast/glycolytic), MYH1 for IIX (fast/glycolytic), MYH2 for 
IIA (fast/oxidative) and MYH7 for type I (slow/oxidative). 
As shown in Fig. 1, mRNA levels of MYH4 and MYH2 
(isoforms specific for type IIB and IIA fibers, respectively) 
were significantly increased in HFD rabbits when compared 
to RD group (Fig. 1A and C; P < 0.05). In contrast, HFD 
muscle samples showed a significant decrease of the type 
I marker MYH7 (Fig. 1D; P < 0.05 vs RD). TTh significantly 
counteracted the HFD-induced changes for both MYH4 
and MYH7 mRNA expression (Fig. 1A and D; P < 0.001 and 
P < 0.05 vs HFD, respectively), while increased MYH1 and 
further increased MYH2 mRNA (Fig. 1B and C; P < 0.05 
and P < 0.001, respectively). Moreover, the TBX15 gene, 
encoding a transcription factor specifically expressed in 
glycolytic myofibers, resulted increased in HFD samples 
(Fig. 1E; P < 0.05 vs RD) and decreased up to the control 
level by TTh (Fig. 1E; P < 0.05 vs HFD).
Histomorphological analysis by PAS staining of 
muscle cross-sections confirmed results from mRNA 
expression. Based on PAS staining intensity, indicative of 
glycogen content, fibers were classified as light-, medium- 
or dark-stained, ranging from oxidative to glycolytic. The 
staining showed a pronounced shift from light PAS-stained 
(oxidative) to medium/dark PAS-stained (glycolytic) fibers 
in muscle sections from HFD animals (Fig. 2). In particular, 
HFD muscles exhibited a significant reduction of light 
PAS-stained fibers (P < 0.001) and a significant increase 
in medium PAS-stained fibers (P < 0.01), as compared to 
RD muscles (Fig. 2D). TTh significantly increased light-
stained fibers (Fig. 2D; P < 0.05 vs RD, P < 0.001 vs HFD) 
and decreased medium-stained fibers (Fig. 2D; P < 0.05 
vs RD, P < 0.001 vs HFD). These changes in fiber type 
composition were confirmed by measuring SDH enzyme 
activity as marker of oxidative fibers using a specific 
staining on muscle sections (Fig. 2E, F, G and H). In HFD 
muscle sections, the percentage of SDH-positive fibers 
was significantly reduced as compared to RD samples 
(Fig. 2H; p < 0.001) and significantly increased by TTh 
(Fig. 2H; P < 0.01).
We next investigated the effect of HFD and TTh 
on fiber diameter and markers of muscle atrophy and 
regeneration. As shown in Fig. 3, HFD reduced fiber 
diameter (P < 0.001 vs RD; Fig. 3A) and increased the 
mRNA expression of the atrophy-related genes, such 
as FBX032/Atrogin 1 (P < 0.01 vs RD; Fig. 3B) and 
MURF1 (P < 0.01 vs RD; Fig. 3C). TTh counteracted the 
HFD-related reduction of fiber diameter (P < 0.001 vs 
HFD, P < 0.05 vs RD; Fig. 3A) and normalized Ta
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FBX032 mRNA expression up to RD level 
(P < 0.001 vs HFD; Fig. 3B). Moreover, TTh significantly 
reduced MURF1 mRNA expression as compared to HFD 
(P < 0.05; Fig. 3C). Interestingly, MYH4 and TBX15 
expression (markers of glycolitic fibers) was positively 
associated with expression of FBX032/Atrogin 1 mRNA 
(r = 0.408, P = 0.015, n = 35 and r = 0.458, P = 0.049, n = 19, 
respectively).
On the other side, the myogenesis-related gene 
myogenin (MYOG) was significantly decreased in HFD 
muscles (Fig. 3D; P < 0.001 vs RD) and restored by TTh 
(Fig. 3D, P < 0.01 vs HFD). TTh also upregulated the 
mRNA expression of two other myogenesis markers, 
such as MYF5 (Fig. 3E, P < 0.001 vs RD and HFD) and 
PAX7 (Fig. 3F, P < 0.01 vs RD and HFD) and the muscle 
differentiation markers MYOD (Fig. 3K, P < 0.01 vs RD 
and HFD) and ITGA7/α7 integrin (Fig. 3L, P < 0.001 vs RD 
and HFD). The myogenic effect of TTh was confirmed by 
immunohistochemistry of PAX7 expression in skeletal 
muscle sections from each rabbit group. As shown in Fig. 
3 (panels G, H, I and J), we found a significant increase of 
PAX7-positive cells in muscle sections from testosterone-
treated rabbits, as compared to both RD and HFD groups 
(P < 0.001). Moreover, using an antibody against MYH3, 
which is expressed by newly generated myofibers, we 
detected MYH3-positive fibers exclusively in muscle 
sections from testosterone-treated HFD rabbits (Fig. 3M).
Accordingly, a positive association was found between 
circulating testosterone and skeletal muscle expression of 
several genes related to muscle regeneration (MYOG, MYF5, 
PAX7, ITGA7), mitochondrial and oxidative metabolism 
(SLC25A12, NDUFB5, UCP2), while the expression of the 
Figure 1
Effect of HFD and TTh on mRNA expression of fiber type markers. (A, B, C and D) mRNA expression of MYH isoforms: MYH4 for type IIB/very fast glycolytic 
fibers (A), MYH1 for type IIX/fast glycolytic fibers (B), MYH2 for type IIA/fast oxidative fibers (C) and MYH7 for type I/slow oxidative fibers (D). (E) mRNA 
expression of the fast glycolytic myofiber marker TBX15. The analyses were performed by quantitative RT-PCR in rabbit skeletal muscle from RD, HFD 
and HFD + testosterone groups. Data were calculated using the 2−ΔΔCt comparative method, with the 18S ribosomal RNA subunit used as reference gene 
for normalization, and are reported as mean ± s.e.m. (n = 15 for each group). Statistical analysis between groups was performed with Kruskal–Wallis and 
post hoc Mann–Whitney non-parametric tests (*P < 0.05 vs RD; °P < 0.05, °°°P < 0.001 vs HFD).
Figure 2
Effect of HFD and TTh on muscle fiber 
composition. (A, B and C) Representative images 
of PAS-stained vastus medialis cross-sections 
from RD (A), HFD (B) and HFD + testosterone (C) 
rabbits showing a shift toward glycolytic more 
intense stained fibers in HFD samples compared 
to RD, that was reverted by TTh; (D) quantification 
of light, medium and dark stained fibers 
calculated by counting ten fields from muscle 
sections of at least three animals for each 
experimental group. (E, F and G) Representative 
images of SDH enzymatic assay in vastus medialis 
cryo-sections from RD (E), HFD (F) and 
HFD + testosterone (G) rabbits showing a 
reduction of SDH activity in HFD sections, 
significantly counteracted by TTh. (H) 
Quantification of SDH-positive fibers calculated by 
counting ten fields of at least three animals for 
each experimental group. Statistical analysis 
between groups was performed with unpaired 
two-sided Student’s t-test (*P < 0.05, **P < 0.01, 
***P < 0.001 vs RD; °°P < 0.01, °°°P < 0.001 vs 
HFD). Scale bar 50 µm. A full colour version of this 
figure is available at https://doi.org/10.1530/
JOE-19-0532.
AUTHOR COPY ONLY
https://doi.org/10.1530/JOE-19-0532
https://joe.bioscientifica.com © 2020 Society for Endocrinology
Published by Bioscientifica Ltd.
Printed in Great Britain
267
Research
E Sarchielli et al. Testosterone favors physical 
activity in MetS
245:2Journal of 
Endocrinology
type IIB marker MYH4 and atrophy marker FBX032 was 
negatively associated with testosterone levels (Table 2).
As reported in Fig. 4, TTh effect on oxidative 
function was confirmed by the significant induction of 
the expression of some mitochondrial respiration-related 
genes, such as NADH dehydrogenase ubiquinone 1 beta 
subcomplex 3 and 5 (NDUFB3 and NDUFB5; P < 0.001 
and P < 0.01 vs both RD and HFD, respectively; Fig. 
4A and B), NADH-ubiquinone oxidoreductase subunit 
1 (NDUFS1; P < 0.05 vs both RD and HFD; Fig. 4C), 
succinate dehydrogenase (SDHB; P < 0.01 vs both RD 
and HFD; Fig. 4D) and citrate synthase (CS; P < 0.01 vs, 
RD, P < 0.05 vs HFD; Fig. 4E). Accordingly, transmission 
electron microscopy studies evidenced mitochondrial 
dysfunctions in HFD muscle samples, with pronounced 
reduction of the internal cristae surface area, as compared 
to RD (Fig. 4F, G and I; P < 0.01 vs RD). TTh counteracted 
the HFD-induced modifications of the mitochondrial 
cristae (Fig. 4H and I; P < 0.05 vs HFD).
To further characterize skeletal muscle metabolism, 
we analyzed the mRNA expression of genes related to 
insulin sensitivity, lipid and energy metabolism (Fig. 5). 
We found that TTh induced a significant increase in 
mRNA expression of insulin receptor substrate‐1 (IRS-1; 
P < 0.001 vs RD and HFD; Fig. 5A), lipoprotein lipase 
(LPL; P < 0.01 vs RD, P < 0.05 vs HFD; Fig. 5B), peroxisome 
proliferator-activated receptor-α (PPARα; P < 0.001 vs RD 
and HFD; Fig. 5C), uncoupled protein-2 (UCP2; P < 0.001 
vs RD and HFD; Fig. 5D) and UCP3 (P < 0.01 vs RD, 
P < 0.05 vs HFD; Fig. 5E). Interestingly, the brown adipose 
Figure 3
Effect of HFD and TTh on fiber size and muscle regeneration/differentiation. (A) Fiber diameter, as measured in muscle cross-sections of specimens from 
RD, HFD and HFD + testosterone rabbits, was reduced by HFD, while TTh counteracted this effect. Data were calculated by ImageJ 1.51f software in ten 
fields from at least three animals for each experimental group and expressed as mean ± s.e.m. Statistical analysis between groups was performed with 
unpaired two-sided Student’s t-test (*P < 0.05 and ***P < 0.001 vs RD, °°°P < 0.001 vs HFD). (B, C, D, E, F and G) TTh normalized the HFD-altered mRNA 
expression of atrophy-related genes, such as FBX032/Atrogin-1 (B) and MURF-1 (C), and the myogenesis-related gene MYOG (D). Also the muscle 
regeneration markers MYF5 (E) and PAX7 (F), the muscle differentiation markers MYOD (K) and ITGA7/α7 integrin (L) were significantly increased by TTh. 
Data were calculated using the 2−ΔΔCt comparative method, with the 18S ribosomal RNA subunit used as reference gene for normalization and are 
reported as mean ± s.e.m. (n = 15 for each group). Statistical analysis was performed with Kruskal–Wallis and post hoc Mann–Whitney non-parametric tests 
(*P < 0.05, **P < 0.01, ***P < 0.001 vs RD; °°P < 0.01, °°°P < 0.001 vs HFD). (G, H, I and J) Immunohistochemical analysis of PAX-7 in vastus medialis muscle 
cross-sections from RD (G), HFD (H) and HFD + testosterone (I) rabbits; (J) quantification of PAX-7-positive cells counted in ten fields from three animals 
for each group and expressed as percentage of RD (mean ± s.e.m.), showing a significant increase of PAX-7 expression in sections from testosterone-
treated HFD rabbits (scale bar 20 µm). Statistical analysis between groups was performed with unpaired two-sided Student’s t-test (***P < 0.001 vs RD; 
°°°P < 0.001 vs HFD). (M) Representative images of the muscle regeneration marker MYH3 in vastus medialis cross-sections, as evaluated by 
immunohistochemical analysis: MYH3-positive fibers are detected exclusively in HFD + testosterone sample (scale bar 20 μm). A full colour version of this 
figure is available at https://doi.org/10.1530/JOE-19-0532.
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tissue-specific UCP1 mRNA was significantly reduced 
by HFD (P < 0.05 vs RD; Fig. 5F) and normalized by TTh 
(P < 0.01 vs HFD; Fig. 5F). Moreover, Oil Red O staining 
showed that skeletal muscle cryosections from HFD rabbits 
presented a lipid intramyocellular accumulation (Fig. 5H), 
which was not present in muscle samples from RD, where a 
light lipid positivity was localized to intermuscular spaces 
(Fig. 5G). These results were paralleled by a significant 
increase of triglyceride content in HFD muscle extracts 
as compared to RD group (P < 0.05; Fig. 5J). Interestingly, 
TTh normalized both lipid content localization (Fig. 5I) 
and triglyceride content (P < 0.05 vs HFD; Fig. 5J).
Effect of physical exercise on skeletal muscle 
composition and metabolism
Since we observed alterations in skeletal muscle induced 
by HFD and ameliorated by TTh, we next evaluated the 
Table 2 Association between gene expression in skeletal muscle samples and circulating testosterone.
Gene r P n
MYF5 (myogenic factor 5) 0.537 0.000 45
PAX7 (paired box 7) 0.390 0.008 45
MYOG (myogenin) 0.472 0.003 38
ITGA7 (skeletal muscle transcripts of the human integrin alpha7) 0.539 0.000 45
SLC25A12 (solute carrier family 25 aspartate/glutamate carrier, member 12) 0.386 0.009 45
NDUFB5 (NADH dehydrogenase ubiquinone 1 beta subcomplex 5) 0.444 0.002 45
MYH4 (myosin, heavy chain 4) −0.424 0.004 45
FBX032 (muscle atrophy F-box) −0.368 0.013 45
UCP2 (uncoupling protein 2) 0.516 0.000 45
Results derived from univariate correlations and are presented as Spearman coefficients. Bold indicates statistical significance.
Figure 4
Effect of HFD and TTh on mitochondrial respiration-related gene expression and mitochondrial cristae aspect. (A, B, C, D and E) Quantitative RT-PCR 
analysis shows a positive effect of TTh on mRNA expression of the mitochondrial respiration-related genes NDUFB3 (A), NDUFB5 (B), NDUFS1 (C), SDHB 
(D) and CS (E). Data were calculated using the 2−ΔΔCt comparative method, with the 18S ribosomal RNA subunit used as reference gene for normalization, 
and are reported as mean ± s.e.m. (n = 15 for each group). Statistical analysis was performed with Kruskal–Wallis and post hoc Mann–Whitney non-
parametric tests (**P < 0.01, ***P < 0.001 vs RD, °P < 0.05, °°P < 0.01, °°°P < 0.001 vs. HFD). (F, G, H and I) Mitochondrial ultrastructure, as visualized by 
transmission electron microscopy in skeletal muscle specimens, was affected by HFD (G) and normalized by TTh (H). Bar graph (I) represents the ratio 
between the cristae membrane surface area and the outer membrane surface area as measured using iTEM image analysis software (SIS) in ten fields of 
muscle sections from at least three animals for each experimental group. Data are reported as mean ± s.e.m. Statistical analysis was performed with 
unpaired two-sided Student’s t-test (**P < 0.01 vs RD; °P < 0.05 vs HFD). Scale bar 500 nm.
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physical endurance and the skeletal muscle functional 
response in terms of fiber composition and metabolism 
in all the experimental groups. We trained a subgroup of 
RD, HFD and HFD + testosterone rabbits with a progressive 
treadmill running protocol for 12 weeks. In HFD rabbits, 
physical activity significantly improved MetS parameters, 
such as hypercholesterolemia, percentage of visceral 
fat and testosterone and LH levels when compared to 
the untrained rabbits (Table 1). Conversely, no effect 
was observed in glucose metabolism, triglycerides 
and mean arterial pressure (Table 1). As expected, in 
testosterone-treated rabbits, physical activity did not 
change LH levels that remained suppressed (Table 1). 
Although the HFD + testosterone + PhyEx group showed 
numerical improvements in some MetS components 
(such as blood glucose, MAP and VAT), the differences 
were not statistically significant, as compared to the 
HFD + testosterone group (Table 1).
Maximum running time and distance on the 
treadmill were utilized to assess the endurance capacity 
of rabbits, exercised on a 20% slope until unable to run 
for 10 s. As showed in Table 3, HFD rabbits were able to 
run for a lower distance and for a shorter time respect 
to RD rabbits, although the lactate production was 
similar in the two groups. When lactate production was 
normalized for running distance, it resulted significantly 
increased by HFD (Table 3). TTh significantly improved 
physical resistance to exercise by increasing both 
maximal running time and distance and normalizing 
lactate production over running distance (Table 3). Table 
3 also shows glycemia levels before and after exercise. 
In RD + PhyEx at the end of exercise glycemia tends to 
increase, whereas in HFD + PhyEx rabbits such an increase 
was not observed, although the pre-exercise levels were 
higher than in control. TTh partially reduced basal 
glycemia and allowed a sustained increase in glycemia 
upon PhyEx.
The effect of endurance training on fiber muscle 
composition was evaluated by PAS staining and SDH 
activity assay (Fig. 6). In HFD + PhyEx muscles, PAS staining 
showed a shift to glycolytic fibers with an increase in 
both medium and dark staining and a parallel reduction 
of light stained fibers (Fig. 6A and B) when compared 
to RD + PhyEx (P < 0.001 and P < 0.05 vs RD + PhyEx, 
respectively, see bar graph in Fig. 6D). TTh was able to 
restore all these alterations up to RD + PhyEx levels (Fig. 
6C and D). These data were confirmed by measuring SDH 
enzyme activity with a specific staining on muscle sections 
(Fig. 6E, F, G and H) and with an enzymatic assay from 
total muscle extracts (Fig. 6I). In HFD + PhyEx samples, 
Figure 5
TTh effect on genes related to insulin sensitivity, lipid and energy 
metabolism and on lipid accumulation in muscle samples. (A, B, C, D, E 
and F) TTh induced mRNA expression of IRS-1, gene related to insulin-
dependent signaling (A), as well as LPL (B) and PPARα (C), genes 
implicated in the lipid metabolism. TTh also increased the expression of 
genes involved in energy dissipation as UCP2 (D) and UCP3 (E) and 
normalized the HFD-altered expression of the brown adipose tissue-
specific UCP1 (F). Data were calculated using the 2−ΔΔCt comparative 
method, with the 18S ribosomal RNA subunit used as reference gene for 
normalization, and are reported as mean ± s.e.m. (n = 15 for each group). 
Statistical analysis between groups was performed with Kruskal–Wallis 
and post hoc Mann–Whitney non-parametric tests (*P < 0.05, **P < 0.01, 
***P < 0.001 vs RD; °P < 0.05, °°P < 0.01, °°°P < 0.001 vs HFD). (G, H and I) 
Oil Red O staining shows intramyocellular lipid accumulation in HFD 
muscle cryosections (H) and intermuscular lipid localization in RD (G) and 
HFD + testosterone (I) muscle sections (scale bar 50 μm). (H) TTh 
normalized the triglycerides content increased by HFD, as evaluated by 
Triglyceride Quantification Kit on muscle lysates from six animals for each 
experimental group; data are reported as mean ± s.e.m. and statistical 
analysis was performed with unpaired two-sided Student’s t-test 
(*P < 0.05 vs RD, °P < 0.05 vs HFD). A full colour version of this figure is 
available at https://doi.org/10.1530/JOE-19-0532.
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the activity of SDH was reduced and restored by TTh (Fig. 
6E, F, G, H and I). Moreover, also the protein expression 
of the subunit A of SDH, evaluated by Western blotting 
of vastus medialis lysates, was significantly increased by 
TTh (Fig. 6J, P < 0.01 vs either RD + PhyEx or HFD + PhyEx). 
Similar results were obtained analyzing the protein 
expression of TOM20, a marker of mitochondrial mass 
(Fig. 6J). To further demonstrate the positive effect of 
TTh on mitochondrial respiration, we measured ATP 
levels in muscle extracts from each experimental trained 
group. Figure 6K shows a significant reduction of ATP 
levels in HFD + PhyEx samples, as compared to RD + PhyEx 
(P < 0.01), that was completely reverted by TTh (P < 0.01 vs 
HFD + PhyEx).
Transmission electron microscopy analysis of 
mitochondria further demonstrated the negative effects 
of HFD on cristae that were maintained also in exercise 
trained rabbits (Fig. 7A and B; P < 0.001 vs RD + PhyEx); 
once again TTh was able to ameliorate mitochondrial 
cristae aspect (Fig. 7C; P < 0.05 vs HFD + PhyEx).
Effect of testosterone supplementation on skeletal 
muscle composition and physical endurance 
in RD group
To evaluate whether testosterone effects could be detected 
also in RD animals, independently of the HFD-induced 
features (including hypogonadism), we analyzed an 
additional group of eugonadal rabbits fed a RD and treated 
with testosterone (30 mg/kg) for 12 weeks. As evaluated 
by both mRNA expression analysis of fiber type markers 
(Table 4) and PAS staining of muscle cross-sections (Fig. 
8A), we found that testosterone supplementation to RD 
did not change skeletal muscle fiber types proportion 
when compared to RD untreated group. No differences 
were also observed in the expression of mitochondrial 
oxidative function-related genes (Table 4). In contrast, 
fiber diameter (Fig. 8B) and mRNA expression of markers 
of both myogenesis and muscle differentiation, such as 
PAX7 (Fig. 8D) and ITGA7 (Fig. 8E), respectively, were 
significantly increased by testosterone supplementation, 
Table 3 Effects of acute exercise in trained RD, HFD and HFD + testosterone rabbits.
Pre-exercise End
P end vs pre-exercise 
within group Recovery
P recovery vs 
pre-exercise 
within group
Running distance (m)
 RD --- 200.00 (159.87; 308.13) --- --- ---
 HFD --- 105.00 (76.88; 154.78)b --- --- ---
 HFD + testosterone --- 225.00 (164.87; 338.50) --- --- ---
Running time (s)
 RD --- 600.00 (479.62; 924.38) --- --- ---
 HFD --- 315.00 (230.65; 464.35)b --- --- ---
 HFD + testosterone --- 675.00 (494.60; 1015.51) --- --- ---
Lactate (nmol/L)
 RD 3.40 (2.38; 6.75) 14.55 (10.37; 19.87) <0.0001 --- ---
 HFD 3.10 (1.86; 7.83) 18.30 (12.42; 20.14) <0.0001 ---
 HFD + testosterone 7.20 (5.02; 10.48) 18.35 (14.07; 21.73) <0.0001 ---
Lactate/running distance (nmol/L for each 100 m)
 RD --- 6.16 (4.15; 11.95) --- --- ---
 HFD --- 16.18 (11.65; 22.73)b --- --- ---
 HFD + testosterone --- 7.36 (5.29; 12.11) --- --- ---
Blood glucose (g/L)
 RD 0.95 (0.76; 1.11) 1.16 (0.92; 1.48) 0.086 1.02 (0.91; 1.15) 0.553
 HFD 1.60 (1.33; 2.26)c 1.94 (1.65; 2.15)b 0.449 1.84 (1.52; 2.29)c 0.537
 HFD + testosterone 1.26 (1.08; 1.68) 1.73 (1.21; 2.69)b <0.0001 1.38 (1.06; 1.60)a 0.223
Triglycerides (mg/dL)
 RD 59.50 (51.50; 81.90) 66.00 (52.77; 86.63) 0.727 60.00 (43.50; 72.50) 0.311
 HFD 139.50 (71.04; 342.96)a 155.50 (67.52; 355.65)a 0.559 162.00 (72.29; 350.38)b 0.581
 HFD + testosterone 111.50 (70.22; 217.18) 120.00 (62.23; 215.77) 0.584 132.00 (87.89; 212.51) 0.449
Measurements were performed before starting (pre-exercise), at the end of the exercise (end) and after 90’ from the exercise (recovery). Results derive 
from multilevel mixed-effect linear regressions (nested within the animals) using the serum parameters as dependent variables and treatment, time of 
exercise and their interaction term as independent variables. The interaction time × treatment is reported using RD as referent. Data are reported as 
median with 95% confidence intervals (in brackets). RD, n = 10; HFD, n = 12 and HFD + testosterone, n = 10.
aP < 0.05, bP < 0.01, cP < 0.0001 vs RD.
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as compared to RD group (P < 0.001 vs RD for fiber diameter; 
P < 0.01 vs RD for PAX7 and ITGA7 mRNA). Accordingly, 
circulating testosterone levels were positively associated 
with fiber diameter (Fig. 8C) and ITGA7 mRNA expression 
(Fig. 8F). Genes related to glucose (PPARα and IRS-1) 
and energy (UCP1, UCP2 and UCP3) metabolism were 
not affected by testosterone, except for the triglyceride 
hydrolysis-related gene LPL, that resulted significantly 
increased (P < 0.001 vs RD; Table 4). Moreover, physical 
endurance evaluation of the subset of RD + testosterone 
rabbits trained with the treadmill protocol was similar to 
that of RD group in terms of running distance, running 
time, lactate production pre- and post-exercise, and 
lactate/running distance ratio, as reported in Table 5. By 
analyzing PAS-stained muscle cross-sections, SDH-positive 
fibers and ATP production in skeletal muscle samples from 
Figure 6
Effect of PhyEx and TTh on muscle fiber composition in each experimental group. (A, B and C) Representative images of PAS-stained vastus medialis 
cross-sections from RD (A), HFD (B) and HFD + testosterone (C) treadmill trained rabbits showing a reduction of light stained fibers and a further shift 
towards medium/dark stained (glycolytic) fibers induced by HFD and normalized by TTh. (D) Quantification of light, medium and dark stained fibers 
calculated by counting at least ten fields from muscle sections of at least three different animals for each experimental group. (E, F, G, H and I) SDH 
enzymatic assay in either vastus medialis cryo-sections or in total muscle extracts shows a reduction of SDH activity in HFD samples, significantly 
counteracted by TTh. (E, F and G) Representative images of SDH staining in muscle sections. (H) The bar graphs show the quantification of SDH-positive 
fibers expressed as percentage of total fibers counted in ten fields from at least three different animals for each group. (I) SDH activity in muscle extracts 
from three animals for each group expressed as percentage of RD + PhyEx, taken as 100%. (J) Representative immunoblots of SDHA and TOM20 in vastus 
medialis protein lysates from each experimental group and quantification of SDHA band intensity normalized over actin signal; data are expressed as 
mean ± s.e.m. and derive from three different animals for each group. (K) Analysis of ATP levels in muscle lysates from RD, HFD and HFD + testosterone 
rabbits after PhyEx protocol expressed as percentage over RD + PhyEx, taken as 100%. Data are from at least six animals for each group. Statistical 
analysis between groups was performed with unpaired two-sided Student’s t-test (*P < 0.05, ***P < 0.001 vs RD; °P < 0.05, °°P < 0.01, °°°P < 0.001 vs HFD). 
Scale bar 50 µm. A full colour version of this figure is available at https://doi.org/10.1530/JOE-19-0532.
Figure 7
Effect of PhyEx and TTh on mitochondrial ultrastructure. (A, B and C) Ultrastructural analysis of skeletal muscle specimens showed mitochondrial 
alterations in HFD samples which were significantly reduced in the samples from TTh-treated animals. (D) Bar graph indicates the ratio between the 
cristae membrane surface area and the outer membrane surface area as measured using iTEM image analysis software (SIS) in ten fields of muscle 
sections from at least three animals for each group. Data are reported as mean ± s.e.m. Statistical analysis was performed unpaired two-sided Student’s 
t-test (***P < 0.001 vs RD; °P < 0.05 vs HFD). Scale bar 500 nm.
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RD + testosterone + PhyEx rabbits, we confirmed that the 
global fiber type composition and metabolism of skeletal 
muscle from RD animals was not significantly affected 
by testosterone supplementation (data not shown). As 
shown in Table 6, testosterone supplementation did not 
change any of the physical and metabolic parameters in 
RD animals either with or without PhyEx, when compared 
to their untreated counterpart, apart from the obvious 
changes in hormonal parameters (Table 6).
Discussion
Change in lifestyle, which includes the increase of physical 
activity, is an important and effective strategy to combat 
MetS-associated hypogonadism (Morelli et  al. 2019). 
However, the ability of MetS subjects to perform physical 
activity might be suboptimal or even compromised, 
due to a detrimental effect of the syndrome on overall 
health and, in particular, on body composition. We here 
demonstrated that TTh in experimental MetS increases 
the capacity to perform physical exercise by improving 
skeletal muscle oxidative activity and ability to sustain 
endurance exercise. Indeed, physical activity is nowadays 
regarded as a major intervention for preventing or halting 
metabolic disturbances, such as those characterizing MetS 
(Bird & Hawley 2017, Wewege et al. 2018). Skeletal muscle 
represents one of the most important tissues in maintaining 
normal whole-body metabolism and energy homeostasis 
because of its high contribution to the whole body mass 
and to its metabolic capacity (Zurlo et  al. 1990). In an 
experimental (HFD-induced) MetS model associated with 
hypogonadism, we recently described a reduced ability of 
rabbits to perform physical exercise (Morelli et al. 2019). 
In the present study, we demonstrate that the reduced 
response to endurance training observed in MetS animals 
was associated with peculiar HFD-induced modifications 
in the skeletal muscle fiber composition and metabolism. 
More relevant, we herein report that when supplemented 
with testosterone, MetS rabbits exhibited skeletal muscle 
morphological and functional features similar to those 
observed in RD animals, including a normalized response 
Table 4 Effects of in vivo testosterone treatment on mRNA expression of target genes in rabbit skeletal muscle.
Gene RD RD + testosterone P
Fiber types:
 MYH1 100.20 (45.30–143.71) 90.93 (85.42–98.88) 0.822
 MYH2 88.67 (60.42–123.63) 132.43 (93.72–166.67) 0.112
 MYH4 60.31 (36.87–164.96) 102.96 (70.37–207.14) 0.379
 MYH7 32.64 (3.65–186.79) 199.75 (50.30–353.00) 0.223
 TBX15 100.43 (75.77–114.24) 93.94 (87.23–147.09) 0.763
Mitochondrial oxidative function:
 CS 88.11 (68.18–129.37) 95.95 (85.99–134.47) 0.510
 NDUFB3 93.12 (60.71–130.26) 105.57 (79.02–119.51) 0.749
 NDUFB5 95.81 (69.86–122.31) 117.18 (79.64–131.27) 0.560
 NDUFS1 76.39 (56.79–143.40) 100.92 (85.39–104.88) 0.533
 SDHB 84.91 (59.00–140.35) 105.89 (96.36–114.82) 0.417
 SLC25A12 93.68 (76.08–123.21) 107.37 (99.73–114.86) 0.395
Atrophy, myogenesis and muscle differentiation:
 FBX032 96.03 (51.46–124.81) 116.80 (99.19–123.92) 0.383
 MYOG 92.87 (73.56–121.41) 136.88 (94.56–168.03) 0.126
 MYF5 92.55 (70.76–129.42) 95.26 (81.81–130.72) 0.704
 PAX7 95.39 (58.55–129.28) 193.65 (138.14–222.75) 0.009
 ITGA7 103.01 (85.64–119.82) 189.02 (137.64–198.60) 0.002
 MYOD 88.42 (55.59–131.58) 98.16 (79.95–126.81) 0.778
Glucose, lipid and energy metabolism:
 PPARA 91.40 (64.15–137.61) 122.31 (84.15–147.87) 0.384
 IRS1 102.30 (80.32–120.49) 152.17 (100.43–163.82) 0.124
 LPL 88.99 (60.41–142.45) 220.93 (211.07–328.42) <0.001
 UCP1 92.13 (64.90–119.98) 102.72 (71.49–111.62) 0.836
 UCP2 90.82 (55.16–135.27) 91.72 (48.56–144.81) 0.953
 UCP3 92.20 (53.01–129.61) 86.68 (47.64–131.79) 0.955
The target genes mRNA expression was evaluated using semi-quantitative RT-PCR in skeletal muscle samples from RD (n = 15) and and RD + testosterone 
(n = 4) rabbits. Data were calculated according to the comparative Ct method, using 18S rRNA subunit as the reference gene for normalization. Results are 
expressed in percentage over RD and are reported as median and quartiles. Bold indicates genes with significantly different expression (P < 0.05) 
comparing RD vs RD + testosterone in the post hoc Mann–Whitney analysis.
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to physical activity. On the other hand, testosterone 
supplementation on otherwise eugonadal rabbits (RD) 
did not result in significant changes in endurance ability, 
although increasing muscle fibers diameter. Given the 
well-known tight link existing between MetS and the 
development of hypogonadism in male population, 
our results add novel insights about the importance 
of considering TTh as a favorable intervention for the 
efficacy of physical activity programs in MetS subjects, 
but not in eugonadal subjects (as it is in doping).
Skeletal muscle is one of the most highly plastic 
tissues, being capable of extensive remodeling in response 
to use, disuse and pathological perturbation. In particular, 
transformations of muscle fiber type may occur to facilitate 
functional adaptations for a muscle’s specific needs, such 
as those requested during physical activity (Schiaffino & 
Reggiani 2011). The functional adaptability of skeletal 
muscle depends upon the type of exercise: resistance 
exercise increases mass and strength, while endurance 
exercise can stimulate mitochondrial biogenesis and 
function, promoting aerobic metabolism. In this regard, 
endurance exercise has been found to be more effective 
in preventing cardiovascular and metabolic diseases (Shen 
et al. 2018).
In this study, we analyzed the vastus medialis 
muscle, a portion of the quadriceps femoris muscle 
group involved in knee extension, characterized by a 
mixed composition of type I/type II fibers and therefore 
useful for studying whether particular conditions could 
induce changes toward another fiber type. Histological 
evaluation of HFD muscle samples showed a reduction 
of slow/type I fibers, which are characterized by the use 
of oxidative metabolism and the ability to perform long-
lasting activities. On the contrary, we demonstrated an 
increased proportion of fast/glycolytic fibers, which rely 
on glycolytic metabolism and may not provide prolonged 
contractions. In fact, the PAS staining showed a reduction 
of light stained fibers and an increase of the medium/
dark stained ones, more rich of glycogen, the substrate 
of anaerobic contractions. Moreover, HFD induced the 
expression of the type IIB glycolytic fiber markers MYH4 
(Schiaffino & Reggiani 2011) and of the mesodermal 
transcription factor testosterone-box 15 (TBX15), a highly 
and specifically expressed transcription factor in glycolytic 
fast-twitch myofibers (Lee et  al. 2015). Interestingly, 
TBX15 ablation determines a shift to oxidative myofibers 
(Lee et  al. 2015). The concomitant reduced expression 
of the type I marker MYH7 in vastus medialis from 
HFD rabbits further demonstrated a morphofunctional 
shift in terms of both fiber composition and contractile 
properties. Interestingly, the aforementioned fiber type 
modifications were accompanied by muscle atrophy and 
by an impairment of myogenic capacity, as demonstrated 
by the reduction of fiber diameter, by the increase of 
the atrophy-related gene FBX032 and by the reduction 
of myogenin gene expression in HFD muscles. Overall, 
these observations are consistent with previous findings 
Figure 8
Effect of TTh on skeletal muscle composition and mRNA expression of 
regeneration/differentiation markers in RD group. (A) Quantification of 
light, medium and dark PAS-stained fibers calculated by counting ten 
fields from muscle sections of at least three animals for each 
experimental group. (B) Fiber diameter, as measured in muscle 
cross-sections of specimens from RD + testosterone group compared to 
RD. Data were calculated by Image J 1.51f software in ten fields from at 
least three animals for each experimental group and expressed as 
mean ± s.e.m. Statistical analysis between groups was performed with 
unpaired two-sided Student’s t-test (*P < 0.001). (C) Relationship between 
fiber diameter and plasma levels of testosterone in the experimental 
groups, as derived from univariate Spearman’s regression analysis. (D 
and E) TTh in RD rabbits significantly increased mRNA expression of the 
myogenesis-related gene PAX7 (D), and the muscle differentiation marker 
ITGA7/α7 integrin (E). Data were calculated using the 2−ΔΔCt comparative 
method, with the 18S ribosomal RNA subunit used as reference gene for 
normalization, and are reported as mean ± s.e.m. (RD, n = 15; 
RD + testosterone, n = 4). Statistical analysis was performed with Kruskal–
Wallis and post hoc Mann–Whitney non-parametric tests. (*P < 0.001). (F) 
Relationship between ITGA7 mRNA and plasma levels of testosterone in 
the experimental groups, as derived from univariate Spearman’s 
regression analysis.
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from human (Stuart et al. 2013) and animal (Denies et al. 
2014) studies, showing that MetS condition, in particular 
insulin resistance, correlates with a higher content of 
glycolytic fibers and with a loss of the oxidative ones. 
In agreement with all these muscle structural changes, 
HFD animals showed a reduced physical performance in 
response to endurance training. Indeed, the HFD-induced 
new asset of muscle composition may account for the 
impairment of exercise performance, since the muscular 
fatigue resistance during endurance training exercises is 
based on the integrity and activity of slow type I/oxidative 
fibers. Interestingly, we found that the reduction of 
muscular oxidative metabolism was exalted by physical 
exercise with a further shift to a glycolytic phenotype, 
thus suggesting the incapability of HFD muscle of 
working through oxidative fibers that instead should be 
normally induced by the endurance training (Pette 2002, 
Shen et al. 2018).
In this regard, our results obtained in the testosterone-
treated HFD group are of particular relevance for two 
reasons: (1) they demonstrate that testosterone was 
able to counteract all the HFD-induced changes in the 
skeletal muscle fiber composition of untrained rabbits, 
maintaining a glycolytic/oxidative fiber ratio similar to 
that of RD group; (2) they suggest that the maintenance 
of a ‘RD-like’ skeletal muscle composition by testosterone 
treatment allowed a normalization in the response to 
physical activity.
It is well known that testosterone exerts trophic 
effects on muscle, mainly promoting protein synthesis, 
fiber hypertrophy and satellite cells/myonuclei proliferation 
and differentiation (Herbst & Bhasin 2004). In fact, TTh 
is regarded an effective approach to increase muscle mass 
and strength in both young and old men with androgen 
deficiency (Bhasin et al. 1997, Bhasin et al. 2018). By using 
a murine model of aging–associated sarcopenia, TTh 
significantly enhanced muscle growth, while increasing 
muscle mass and hypertrophy of both types I and II 
fibers and preventing age-related increase in oxidative 
stress and muscle cell apoptosis (Kovacheva et al. 2010). 
Moreover, TTh also reduced orchiectomy-induced 
expression of several atrophy-related markers in skeletal 
muscle (White et  al. 2013). In line with these anabolic 
and anti-catabolic effects of TTh, present data show a 
positive effect of testosterone on HFD-induced atrophy 
and on the expression of myogenic (MYOG, MYF5, PAX7) 
and differentiation (MYOD and ITGA7) genes that was 
also positively associated with testosterone plasma levels. 
Accordingly, an increase of PAX7 immunopositivity and 
the presence of newly generated MYH3-positive fibers 
were detected in skeletal muscle from testosterone-treated 
HFD rabbits. Noteworthy, we here demonstrate for the 
first time that testosterone normalized the MetS-induced 
shift of type I/II fibers, as demonstrated by PAS staining 
and MYH/Tbx15 gene expression, thereby promoting 
a muscle asset indicative of predominant oxidative 
metabolism, even in untrained rabbits. Accordingly, we 
found that the expression of mitochondrial enzymes 
crucial for cell respiration was not only significantly 
increased in skeletal muscle from testosterone-treated 
HFD rabbits, but also positively correlated to testosterone 
plasma levels. Moreover, ultrastructural analysis of muscle 
samples showed that testosterone was able to maintain 
mitochondrial integrity counteracting HFD-induced 
degeneration of internal membrane cristae. Similar 
results were found also in terms of both ATP production, 
as marker of mitochondrial respiration, and in terms of 
mitochondrial mass, as evaluated by TOM20 protein 
expression. Noteworthy, mitochondrial dysfunction 
is crucially contributing to the complex etiology of 
sarcopenia even in the context of metabolic diseases 
(Coen et  al. 2018). Treatment in male mice increases 
the expression of genes involved in mitochondrial 
biogenesis and heat production in skeletal muscle via an 
AR-dependent pathway (Usui et al. 2014). In addition, in 
men, testosterone correlates with genetic and functional 
markers of mitochondrial function in skeletal muscle 
(Pitteloud et  al. 2005). Therefore, the positive effects of 
testosterone treatment in MetS animals on fatigue resistant 
fibers and mitochondrial integrity – substantiated by a 
Table 5 Effects of physical exercise in testosterone-treated RD rabbits.
RD + testosterone + PhyEx (n = 4) p vs RD + PhyEx 
Running distance (m) 204.00 (189.30; 218.70) 0.839
Running time (s) 612.00 (567.90; 656.10) 0.839
Lactate (nmol/L) Pre-exercise: 2.70 (0.86; 4.54)
 End: 17.2 (2.87; 31.53)
0.374
0.839
Lactate/running distance (nmol/L for each 100 m) 8.59 (0.95; 16.23) 0.8393
Measurements were performed before starting (pre-exercise) and at the end of the exercise (end). The P value is vs the relative RD group of Table 3, 
untreated with testosterone. Data are reported as median with 95% confidence intervals (in brackets).
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significant improvement in the exercise performance and 
by the reduced lactate production – might be one of the 
major underlying mechanisms of TTh-induced metabolic 
improvements.
Altered glucose and lipid metabolism in HFD rabbits 
could thus be the cause of skeletal muscle modifications. 
Hence, we speculate that the amelioration of some MetS 
parameters (in particular fasting glucose levels, glucose 
tolerance and visceral adipose tissue accumulation) upon 
testosterone treatment could indirectly contribute to the 
normalization and/or improvement in skeletal muscle 
feature. Consistent with this hypothesis, we also found that 
TTh counteracted HFD-induced i.m. lipid accumulation. 
Recent studies demonstrated that a western-like diet may 
induce changes in skeletal muscle metabolism that promote 
lipid utilization over glucose oxidation as substrates of 
mitochondrial respiration (McCurdy et al. 2016, Gonzalez-
Armenta et  al. 2019). These changes were associated to 
a decrease in oxidative capacity and an impairment of 
glucose metabolism. Moreover, measures of mitochondrial 
respiration in response to fatty acids were significantly and 
positively correlated with insulin resistance (Gonzalez-
Armenta et  al. 2019) We did not analyze specific effects 
of HFD, with and without testosterone administration, 
on mitochondrial bioenergetics. However, our results, 
concerning HFD-induced and testosterone-counteracted 
skeletal muscle changes – including mitochondrial 
structural alterations, lipid accumulation, reduced content 
of oxidative fibers, as well as reduced oxidative metabolism 
– suggest that all these changes are associated to the 
diet composition. In addition, our results indicate that 
testosterone treatment counteracted these HFD-induced 
muscle changes, most likely facilitating muscle glucose 
uptake and oxidative metabolism, and this could be related 
to the maintenance of an intact mitochondrial structure.
In physiological conditions, blood glucose, plasma-
free fatty acids, muscle glycogen, and i.m. triglycerides 
are the major substrate sources for energy production 
in skeletal muscles. In particular, during exercise, blood 
glucose level can be increased primarily by means 
of an augmented glycogenolysis in the liver (Brooks 
et  al. 2005). On the contrary, impairment of blood 
glucose homeostasis under MetS condition is associated 
with insulin resistance and altered glucose uptake by 
skeletal muscle. Accordingly, in RD + PhyEx, at the end 
of exercise, glycemia tended to increase, whereas in 
HFD + PhyEx rabbits the high glycemic levels remained 
unchanged. TTh partially reduced basal glycemia and 
allowed a sustained increase in glycemia upon PhyEx, 
thus suggesting a restoration of the glucose mobilization 
as important source of substrate for exercising muscle. 
However, based on our results we cannot rule out that 
metabolic improvements following TTh may be a 
consequence of positive direct effects of testosterone on 
skeletal muscle ability in metabolizing glucose and lipids. 
In this regard, we observed an up-regulation of IRS1 gene 
in the vastus medialis of testosterone-treated rabbits, in 
line with a previous study that obtained the same results 
on castrated rats treated with testosterone (Wu et  al. 
2010). Similarly, we report a positive effect of testosterone 
on the expression of genes involved in regulating lipid 
metabolism in skeletal muscle, such as PPARα, LPL and 
UCPs. In human skeletal muscle, expression of PPARα and 
of other genes regulating lipid metabolism, in particular 
LPL, are tightly related (Zhang et al. 2004). LPL activity, 
especially in oxidative muscle, is normally high to allow 
the release of free fatty acids and their subsequent uptake 
by myofibers, for energy production. UCPs are proteins 
located in the mitochondrial inner membrane with the 
function to uncouple the oxidation of fuels, mainly fatty 
acids, from ATP production, so the energy associated 
with oxidation is dissipated as heat (Bouillaud et  al. 
2016). Mitochondrial uncoupling and the consequent 
energy dissipation are of great importance in relation 
Table 6 Metabolic parameters of testosterone-treated RD rabbits with and without PhyEx.
RD + testosterone (n = 4) P vs RD RD + testosterone + PhyEx (n = 4) P vs RD + PhyEx 
Total body weight (kg) 3.75 (3.63–4.18) 0.885 3.72 (3.59–3.84) 0.454
Blood glucose (g/L) 0.97 (0.86–1.08) 0.262 0.93 (0.81–0.98) 0.304
OGTT (iAUC) 141.70 (130.12–176.07) 0.307 147.50 (137.67–155.30) 0.304
Cholesterol (mg/dL) 49.00 (48.25–49.75) 0.665 49.50 (48.25–50.00) 0.773
Triglycerides (mg/dL) 124.00 (88.50–149.00) 0.062 75.00 (67.50–87.00) 0.142
MAP (mmHg) 78.43 (65.00–96.09) 0.810 84.00 (80.00–88.00) 0.414
VAT (g/kg of total weight) 8.98 (7.43–9.85) 0.961 8.50 (7.66–9.35) 0.454
Testosterone (nmol/L) 51.20 (39.18–60.40) 0.001 71.60 (55.40–93.50) 0.003
LH (ng/mL) 0.05 (0.02–0.09) 0.014 0.06 (0.02–0.07) 0.014
Results are reported as medians with quartiles in brackets. The p value is vs the relative group of Table 1, untreated with testosterone.
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to obesity, diabetes, and MetS (Li et  al. 2018). UCP1 is 
highly expressed in brown adipose tissue with thermogenic 
function. However, an ectopic expression of UCP1 in the 
skeletal muscle of transgenic mice is associated with an 
increase of whole-body energy expenditure, resulting 
in the restoration of insulinemia, cholesterolemia and 
adiposity, and a decrease of type IIB fiber content (Li et al. 
2000, Couplan et al. 2002). Moreover, UCP1 expression in 
the skeletal muscle of transgenic mice protects them from 
HFD-induced obesity-associated disturbances of glucose 
homeostasis (Katterle et  al. 2008). UCP2 and UCP3 are 
broadly expressed UCP isoforms and their expression is 
upregulated after starvation and correlates with the use 
of fatty acids as mitochondrial substrates, suggesting a 
novel role, different from the uncoupling one (Bouillaud 
et al. 2016).
Generation of genetically modified knock-out (KO) 
mouse models in which the androgen receptor (AR) 
has been deleted either globally or in a tissue- 
and/or cell-specific manner gave also important insights 
into the mechanism by which androgens act on the 
musculoskeletal system. In global-ARKOs muscle mass 
was decreased by up to 20% compared with wild-type 
males (MacLean et al. 2008, Ophoff et al. 2009). However, 
in contrast with our observations, ARKO mice showed 
less fast-twitch (type II) and reduced contractile strength 
accompanied by an increase in the content of slow-twitch 
(type I) fibers (MacLean et al. 2008, Ophoff et al. 2009). 
The discrepancy indicates that the metabolic background 
may interfere with the testosterone actions on skeletal 
muscles as expected only considering the classical 
AR-mediated pathway. Moreover, data from several 
muscle-specific ARKOs, including those targeting satellite 
cells, myocytes, myoblasts, and/or myofibers, provide 
evidence for a partial direct role of androgens via the AR in 
skeletal muscle to regulate its mass (Chambon et al. 2010, 
Rana et al. 2016). So it seems that other sites of action of 
testosterone might contribute in mediating the anabolic 
effects of testosterone on skeletal muscle mass. Indeed, a 
neuron-ARKO mouse model in which the AR is deleted 
specifically in neurons in the brain clearly demonstrated 
that brain AR acts to positively regulate hind-limb mass 
(Davey et al. 2017).
The most intriguing finding of our study is 
the demonstration that treating HFD rabbits with 
testosterone was able to allow a normal exercise capacity 
that was impaired before. This is tantamount to say that 
a testosterone supplementation might help MetS subjects 
to be able to perform physical exercise. Interestingly, 
when we treated with testosterone an additional group 
of RD rabbits with normal level of testosterone, we did 
not observe any significant effects either on muscle fiber 
composition and metabolism or in terms of response to 
physical activity. We only evidenced a trophic effect, as 
demonstrated by an increased fiber diameter, as well as 
by an induction of some genes related to myogenesis, 
including PAX7 and ITGA7. Accordingly, testosterone 
plasma levels was positively associated with fiber diameter 
and ITGA7 mRNA expression in RD group, further 
supporting the view of a trophic effect of testosterone 
independently of HFD. Consistent with our findings, it 
has been demonstrated that testosterone administration 
in supraphysiological doses to healthy eugonadal men 
is associated with significant increases in muscle size 
due to muscle fiber hypertrophy without changing the 
relative proportions of type I and type II fibers (Sinha-
Hikim et al. 2002). Overall, testosterone treatment in RD 
rabbits did not change the global metabolic conditions 
and affected the skeletal muscle features at a little extent, 
if compared to that observed in testosterone-treated 
HFD group. Hence, we can hypothesize that the positive 
effects of testosterone observed in the HFD group are 
linked to HFD-induced features, including testosterone 
deficiency, and not a mere androgenic effect, thus 
further supporting the use of TTh in pathological 
conditions characterized by hypogonadism but not in 
eugonadal subjects.
A recent meta-analysis of intervention studies in 
hypogonadal patients with metabolic derangements 
reported that combination of testosterone 
supplementation and lifestyle modifications was able 
to improve, more than lifestyle change itself, body 
composition (reduction of fat mass and increase in lean 
mass), leading to an amelioration of lipid profile and 
insulin resistance (Corona et al. 2015). Whether or not TTh 
could ameliorate exercise performance in MetS remains to 
be investigated. In fact, the available studies on the effect 
of testosterone supplementation on muscle strength and 
function were mainly conducted in older men and results 
are controversial. In a RCT, which compared older healthy 
men with low-to-normal testosterone levels receiving TTh 
or placebo for 3 years, a modest but significant improvement 
in muscle mass and power was shown in the active arm 
(Storer et  al. 2017). Accordingly, in the ‘Testosterone 
Trials’, a coordinated set of seven placebo-controlled, 
double-blind trials aimed at determining the efficacy of 
increasing testosterone levels of older men with androgen 
deficiency, a small benefit was reported with respect to 
walking performance in hypogonadal patients following 
12 weeks of testosterone therapy (Snyder et  al. 2018). 
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However, this improvement was not confirmed when 
only older hypogonadal men with limited mobility were 
considered (Snyder et  al. 2016). Conversely, in a trial 
involving more than 200 elderly hypogonadal men with 
limitations in mobility randomly treated with TTh or 
placebo for 9 months, a significant improvement in leg- 
and chest-press strength as well as in stair-climbing power 
was associated with TTh (Basaria et  al. 2010). A recent 
reanalysis of systematic reviews and meta-analyses on 
the topic suggests that, in older men with clinical muscle 
weakness and low testosterone levels, treatment can 
be justified in daily clinical practice to improve muscle 
mass, muscle strength and/or physical performance (De 
Spiegeleer et al. 2018).
In conclusion, in an animal model of MetS, associated 
with hypogonadism, TTh showed a positive effect not 
only in ameliorating the glycometabolic profile, but also 
in modifying the morpho-functional features of skeletal 
muscles. Indeed, following testosterone treatment, HFD 
muscles were almost comparable to RD muscles. In 
fact, fiber muscle composition, mitochondria features 
and SDH activity were all improved and shifted toward 
an oxidative metabolism, instead of a glycolytic one. 
All the observed muscle modifications resulted in 
a better exercise performance. Accordingly, in aged 
male mice, testosterone administration, along with 
a low-intensity physical training, improved skeletal 
muscle mitochondrial biogenesis/quality and physical 
performance (Guo et al. 2012). Adequate clinical studies 
are required to confirm also in humans results obtained 
in these animal models. Our findings support the use 
of TTh in MetS as an intervention to favor lifestyle 
correction and, in particular, the adherence to physical 
exercise programs. As soon as lifestyle changes are 
established and could orchestrate their favorable effects 
(Morelli et  al. 2019) the need for further testosterone 
supplementation can be reconsidered. Finally, our data 
do not suggest the use of testosterone administration 
to otherwise eugonadal individuals to improve aerobic 
endurance performances.
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